Self-Screening Tests to Identify Anxiety in Rheumatic Disease

This article originally appeared here.
Share this content:
"The use of a self-applied screening tool can help clinicians to properly detect depression and anxiety associated with diverse rheumatic diseases."
"The use of a self-applied screening tool can help clinicians to properly detect depression and anxiety associated with diverse rheumatic diseases."

WASHINGTON, DC — Researchers have found that anxiety and depression are prevalent in multiple rheumatic diseases, and that self-applied screening tests can help properly detect them in patients. The findings were presented at the 2016 ACR/ARHP Annual Meeting, November 11-16, 2016 in Washington, DC.1

A total of 410 patients (339 women (82.8%)) who had attended an outpatient Rheumatology clinic at the Instituto Nacional de Cardiologia Ignacio Chavez in Mexico City from March to June 2016 were recruited. The participants filled out the Patient Help Questionnaire-9 (PHQ-9) to measure depression, and the General Anxiety Disorder-7 (GAD-7) to assess anxiety.

The researchers found that 191 patients (46.6%) reported depressive symptoms (PHQ-9 >5), and of those, 87 (21.2%) had moderate depression or worse (PHQ-9>10). Of 168 patients (40.7%) who reported symptoms of anxiety, 67 (16.2%) had moderate to severe anxiety.

“We demonstrated that the use of a self-applied screening tool can help clinicians to properly detect depression and anxiety associated with diverse rheumatic diseases,” wrote the authors. “Special attention should be paid to patients with fibromyalgia and osteoarthritis.”

Follow @ClinicalPainAdv

Reference

  1. Perez-Garcia LF, Rivera V, Moreno Ramirez M, et al. Screening for depression and anxiety in an outpatient rheumatology clinic using validated self-applied questionnaires. Presented at: 2016 ACR/ARHP Annual Meeting. November 11-16, 2016; Washington, DC. Abstract #1173.
You must be a registered member of Clinical Pain Advisor to post a comment.